SHIVTEXCHEM Shiv Texchem Q4 FY25 results (Jan–Mar 2025) and concall
Shiv Texchem reported a strong H2 and FY25, with significant revenue and profit growth driven by both existing products and new SKU additions. EBITDA margins expanded to 4.4% in H2, exceeding expectations. While management emphasized sustainable growth in niche chemicals, concerns were raised regarding increased receivable days and the need for a potential fundraise to support future expansion.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY24 | Q4 FY24 | Q2 FY25 | Q4 FY25 |
|---|---|---|---|---|
| Revenue | 613 | 922 | 1,031 | 1,171 |
| EBITDA | 23 | 35 | 35 | 51 |
| Net profit | 11 | 19 | 21 | 27 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
